Global Joint Disorders Market, By Type (Osteoarthritis, Rheumatoid Arthritis, Spondylarthritis, Juvenile Idiopathic Arthritis, Lupus, Gout, Bursitis, Others), Diagnosis (Physical Examination, X-ray, MRI, Ultrasound, Blood Test, DEXA Scan, Others), Treatment (Medication, Therapy, Surgery, Others), Route of Administration (Oral, Parenteral, Topical, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) – Industry Trends and Forecast to 2029.
Joint Disorders Market Analysis and Size
The global joint disorders market is expected to witness significant growth during the forecast period. Rising cases arthritis and other joint disorders boosts the joint disorders market. Adaptation of unhealthy lifestyle, rising stress in daily life and malnutrition and family history with joint disorders also boost up the the market growth. COVID-19 also had left a major impact on the population and the market growth.
Data Bridge Market Research analyses a growth rate in the global joint disorders market in the forecast period 2022-2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Joint disorders are the type of condition that involves inflammation, congenital deformity, infection, neoplasm, chronic repetitive injury and acute injury degeneration in body joints. Joint disorders can occur at any age but research has showed that joint disorders are more prevalent between the age group of 40 to 65 years. Generally, females are at higher risk of having joint disorders than males. Symptoms of joint disorders are fatigue, decreased range of motion, joint stiffness, decreased joint function, and painful swelling among others.
Joint Disorders Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Osteoarthritis, Rheumatoid Arthritis, Spondylarthritis, Juvenile Idiopathic Arthritis, Lupus, Gout, Bursitis, Others), Diagnosis (Physical Examination, X-ray, MRI, Ultrasound, Blood Test, DEXA Scan, Others), Treatment (Medication, Therapy, Surgery, Others), Route of Administration (Oral, Parenteral, Topical, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Pfizer Inc. (U.S.), Abbvie Inc. (U.S.), Novartis AG (Switzerland), Amgen Inc. (U.S.), Boehringer Ingelheim International GmbH. (Germany), Samsung Bioepis. (South Korea), Merck & Co Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Teva Pharmaceuticals Industries Ltd. (Israel), AstraZeneca (U.K.), Vintage Labs (India)
|
|
Market Opportunities
|
|
Global Joint Disorders Market Dynamics
Drivers
- High Prevalence of Arthritis
Its been witnessed that more than 350 million people have arthritis all over the globe .In the U.S., 1 in 4 adults have been reported with arthritis in 2020. It’s estimated to be 78 million by the year 2040. This boosts the market growth.
- Increased alcohol intake
Increased alcohol consumption is expected to drive the expansion of the joint disorders market during the forecast period as a result of the association between increased incidence of joint disorders and alcohol consumption.
Opportunities
- Increase in Elderly Population
Life expectancy is growing around the world, which has led to an increase in the aging population. This trend positively impacts the industry by increasing the incidence of the disease and creating per capita demand for its remedies.
Restraints/Challenges
- Lack of skilled professionals
The lack of qualified personnel who are unable to perform the treatments could curb the growth of the global joint disorders market over a forecast period.
- High Cost
The huge expenditure required for treatment process surely hamper the market growth.
This global joint disorders market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global joint disorders market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Global Joint Disorders Market
With the onset of COVID-19, several countries abandoned all non-emergency surgical procedures so that healthcare professionals only focus on patients with COVID-19. Thus, the market faced a huge loss during the pandemic. Although, during the thisrd wave and post-pandemic era, the market witnessed an outgrow and started working rapidly through a significant backlog of postponed surgeries.
Global Joint Disorders Market Scope
The global joint disorders market is segmented on the basis of type, diagnosis, treatment, route of administration, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Osteoarthritis
- Rheumatoid Arthritis
- Spondylarthritis
- Juvenile Idiopathic Arthritis
- Lupus
- Gout
- Bursitis
- Others
Diagnosis
- Physical Examination
- X-ray
- MRI
- Ultrasound
- Blood Test
- DEXA Scan
- Others
Treatment
- Medication
- Therapy
- Surgery
- Others
Route of Administration
- Oral
- Parenteral
- Topical
- Others
End-Users
- Hospitals
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
Joint Disorders Market Regional Analysis/Insights
The global joint disorders market is analysed and market size insights and trends are provided by type, diagnosis, treatment, route of administration, end-user and distribution channel as referenced above.
The major countries covered in the global joint disorders market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the market due to high prevalence of joint disease, and technological advancements in early diagnosis of the disease
Asia-Pacific is expected to account for the largest market share due to increased joint replacement surgeries and rapidly improving health care infrastructure in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Joint Disorders Market Share Analysis
The global joint disorders market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global joint disorders market
Key players operating in the global joint disorders market include:
- Pfizer Inc. (U.S.)
- Abbvie Inc. (U.S.)
- Novartis AG (Switzerland)
- Amgen Inc. (U.S.)
- Boehringer Ingelheim International GmbH. (Germany)
- Samsung Bioepis. (South Korea)
- Merck & Co Inc. (U.S.)
- Sun Pharmaceutical Industries Ltd. (India)
- Teva Pharmaceuticals Industries Ltd. (Israel)
- AstraZeneca PLC (U.K.)
- Vintage Labs (India)
SKU-